{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:01:09Z","timestamp":1791219669824,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/jcp.0b013e3182825bfd","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T08:47:44Z","timestamp":1360918064000},"page":"199-205","source":"Crossref","is-referenced-by-count":41,"title":["Donepezil Treatment Stabilizes Functional Connectivity During Resting State and Brain Activity During Memory Encoding in Alzheimer\u2019s Disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Cristina","family":"Sol\u00e9-Padull\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bartr\u00e9s-Faz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Llad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleof\u00e9","family":"Pe\u00f1a-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Castellv\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Bargall\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00702-006-0579-2","article-title":"The significance of the cholinergic system in the brain during aging and in Alzheimers disease.","volume":"113","author":"Schliebs","year":"2006","journal-title":"J Neural Transm"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00019052-200208000-00007","article-title":"Neuropsychiatric symptoms in the dementias.","volume":"15","author":"Assal","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbr.2010.11.052","article-title":"Acetylcholine and memory: a long, complex and chaotic but still living relationship.","volume":"10","author":"Micheau","year":"2011","journal-title":"Behav Brain Res"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":". Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimers fibrils.","volume":"18","author":"Alvarez","year":"1998","journal-title":"J Neurosci"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1567205054367928","article-title":". Acetylcholinesterase-amyloid-beta-peptide interaction: effect of Congo Red and the role of the Wnt pathway.","volume":"2","author":"Inestrosa","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/156720509787313961","article-title":". Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.","volume":"6","author":"Nordberg","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00004714-200212000-00012","article-title":". Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimers disease.","volume":"22","author":"Kaasinen","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00019442-200303000-00007","article-title":". Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study.","volume":"11","author":"Tune","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00213-006-0408-1","article-title":". Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimers disease: a double-blind cross-over trial.","volume":"187","author":"Teipel","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R10-9-20210128","first-page":"1441","article-title":". Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimers disease.","volume":"42","author":"Nakano","year":"2001","journal-title":"J Nucl Med"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S1388-2457(02)00110-4","article-title":". Effects of long-term Donepezil therapy on rCBF of Alzheimers patients.","volume":"113","author":"Nobili","year":"2002","journal-title":"Clin Neurophysiol"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1051228405001468","article-title":". SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimers disease.","volume":"16","author":"Shimizu","year":"2006","journal-title":"J Neuroimaging"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12149-007-0022-2","article-title":". Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimers disease.","volume":"21","author":"Yoshida","year":"2007","journal-title":"Ann Nucl Med"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/brain\/awh177","article-title":". Cholinergic enhancement of frontal lobe activity in mild cognitive impairment.","volume":"127","author":"Saykin","year":"2004","journal-title":"Brain"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3174\/ajnr.A1359","article-title":". Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging.","volume":"30","author":"Petrella","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"R16-9-20210128","first-page":"1006","article-title":". Cortical activation during cholinesterase-inhibitor treatment in Alzheimer disease: preliminary findings from a pharmaco-fMRI study.","volume":"13","author":"Kircher","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/156720510791383877","article-title":". Established donepezil treatment modulates task relevant regional brain activation in early Alzheimers disease.","volume":"7","author":"McGeown","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.0308627101","article-title":". Default-mode network activity distinguishes Alzheimers disease from healthy aging: evidence from functional MRI.","volume":"30","author":"Greicius","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-9-20210128","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuroimage.2005.12.033","article-title":". Changes in hippocampal connectivity in the early stages of Alzheimers disease: evidence from resting state fMRI.","volume":"31","author":"Wang","year":"2006","journal-title":"Neuroimage"},{"key":"R20-9-20210128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2008.08.012","article-title":". Detection of PCC functional connectivity characteristics in resting-state fMRI in mild Alzheimers disease.","volume":"30","author":"Zhang","year":"2009","journal-title":"Behav Brain Res"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/hbm.21153","article-title":". Altered default mode network connectivity in Alzheimers diseasea resting functional MRI and Bayesian network study.","volume":"32","author":"Wu","year":"2011","journal-title":"Hum Brain Mapp"},{"key":"R22-9-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1440.011","article-title":"The brains default network: anatomy, function, and relevance to disease.","volume":"1124","author":"Buckner","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R23-9-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","article-title":". Amyloid deposition is associated with impaired default network function in older persons without dementia.","volume":"30","author":"Sperling","year":"2009","journal-title":"Neuron"},{"key":"R24-9-20210128","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jmri.22662","article-title":". Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimers disease patients treated with donepezil assessed by resting-state fMRI.","volume":"34","author":"Goveas","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"R25-9-20210128","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000109750","article-title":". Longitudinal study of amnesic patients at high risk for Alzheimers disease: clinical, neuropsychological and magnetic resonance spectroscopy features.","volume":"24","author":"Rami","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R26-9-20210128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pscychresns.2010.12.001","article-title":". Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimers disease continuum.","volume":"30","author":"Sole-Padulles","year":"2011","journal-title":"Psychiatry Res"},{"key":"R27-9-20210128","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.neurobiolaging.2007.10.008","article-title":". Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimers disease.","volume":"30","author":"Sole-Padulles","year":"2009","journal-title":"Neurobiol Aging"},{"key":"R28-9-20210128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hbm.1048","article-title":". A method for making group inferences from functional MRI data using independent component analysis.","volume":"14","author":"Calhoun","year":"2001","journal-title":"Hum Brain Mapp"},{"key":"R30-9-20210128","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.neuron.2010.02.005","article-title":". Functional-anatomic fractionation of the brains default network.","volume":"25","author":"Andrews-Hanna","year":"2010","journal-title":"Neuron"},{"key":"R31-9-20210128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cne.903180308","article-title":". Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study.","volume":"15","author":"Mesulam","year":"1992","journal-title":"J Comp Neurol"},{"key":"R32-9-20210128","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1073\/pnas.98.2.676","article-title":". A default mode of brain function.","volume":"16","author":"Raichle","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-9-20210128","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.neuroimage.2004.07.031","article-title":"When less means more: deactivations during encoding that predict subsequent memory.","volume":"23","author":"Daselaar","year":"2004","journal-title":"Neuroimage"},{"key":"R34-9-20210128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cercor\/bhq051","article-title":". What goes down must come up: role of the posteromedial cortices in encoding and retrieval.","volume":"21","author":"Vannini","year":"2011","journal-title":"Cereb Cortex"},{"key":"R35-9-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12017-009-8109-7","article-title":". Functional alterations in memory networks in early Alzheimers disease.","volume":"12","author":"Sperling","year":"2010","journal-title":"Neuromolecular Med"},{"key":"R36-9-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JCP.0b013e31819a8f2e","article-title":". Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.","volume":"29","author":"Bokde","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R37-9-20210128","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.mri.2007.02.005","article-title":". Regional brain activity after prolonged cholinergic enhancement in early Alzheimers disease.","volume":"25","author":"Shanks","year":"2007","journal-title":"Magn Reson Imaging"},{"key":"R38-9-20210128","first-page":"465","article-title":"Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimers disease.","volume":"4","author":"McGeown","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R39-9-20210128","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pneurobio.2011.05.012","article-title":". Recent developments of functional magnetic resonance imaging research for drug development in Alzheimers disease.","volume":"95","author":"Hampel","year":"2011","journal-title":"Prog Neurobiol"},{"key":"R40-9-20210128","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/mp.2011.62","article-title":". Neuroimaging as endpoints in clinical trials: are we there yet Perspective from the first Provence workshop.","volume":"31","author":"Valenzuela","year":"2011","journal-title":"Mol Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182825bfd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:57Z","timestamp":1620957657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201304000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182825bfd","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}